Immix Biopharma Income Statement (2020-2026) | IMMX

Income Statement Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity) (Quarter)
3.38M3.67M13.86M13.95M13.96M13.96M14.02M16.33M19.68M19.99M26.47M27.50M27.55M27.61M27.92M28.48M33.11M32.97M53.08M71.61M
Operating items
Research & Development (Quarter)
0.03M0.01M0.63M0.61M0.70M2.26M1.32M2.21M2.11M3.10M3.25M2.22M4.45M1.37M1.98M3.97M4.58M5.73M5.98M5.33M
Selling, General & Administrative (Quarter)
0.32M0.59M0.70M0.95M0.84M1.53M1.20M1.51M2.42M2.28M2.34M2.48M2.95M3.61M2.71M2.75M3.08M5.17M4.82M7.12M
Operating Expenses (Quarter)
0.35M0.60M1.33M1.56M1.53M3.79M2.52M3.72M4.52M5.38M5.59M4.70M7.39M4.99M4.68M6.72M7.66M10.89M10.80M12.46M
Operating Income (Quarter)
-0.35M-0.60M-1.33M-1.56M-1.53M-3.79M-2.52M-3.72M-4.52M-5.38M-5.59M-4.70M-7.39M-4.99M-4.68M-6.72M-7.66M-10.89M-10.80M-12.46M
EBIT (Quarter)
-0.35M-0.60M-1.33M-1.56M-1.53M-3.79M-2.52M-3.72M-4.52M-5.38M-5.59M-4.70M-7.39M-4.99M-4.68M-6.72M-7.66M-10.89M-10.80M-12.46M
Non-operating items
Interest & Investment Income (Quarter)
0.03M0.13M0.19M0.23M0.27M0.31M0.26M0.19M0.15M0.10M0.08M0.22M0.72M0.91M
Other Non Operating Income (Quarter)
0.73M
Non Operating Income (Quarter)
-0.05M-22.16M-388.00-109.000.03M0.13M0.19M0.23M0.27M0.31M0.26M0.19M0.15M0.10M0.08M0.22M0.72M0.91M
Net income details
EBT (Quarter)
-0.40M-22.75M-1.33M-1.56M-1.53M-3.79M-2.49M-3.59M-4.34M-5.15M-5.32M-4.40M-7.14M15.31M-4.53M-6.61M-7.58M-10.68M-10.09M-11.54M
Tax Provisions (Quarter)
0.00M0.00M0.00M0.00M0.00M-1.74M0.01M0.01M0.01M-4.33M0.01M0.01M0.01M0.01M0.01M0.01M0.01M-8.26M0.01M
Profit After Tax (Quarter)
-0.40M-22.76M-1.33M-1.56M-1.54M-3.80M-2.50M-3.60M-4.31M-4.99M-5.33M-4.41M0.08M16.67M-4.53M-6.62M-7.59M-10.71M-10.09M-11.56M
Income from Non-Controlling Interests (Quarter)
-0.02M-0.02M-0.06M-0.07M-0.07M-0.01M0.07M-0.01M
Income from Continuing Operations (Quarter)
-0.40M-22.76M-1.33M-1.56M-1.54M-2.05M-2.50M-3.60M-4.34M-0.82M-5.33M-4.41M-7.15M15.30M-4.54M-6.62M-7.59M-2.41M-10.09M-11.56M
Consolidated Net Income (Quarter)
-0.40M-22.76M-1.33M-1.56M-1.54M-2.05M-2.50M-3.60M-4.34M-0.82M-5.33M-4.41M-7.15M15.30M-4.54M-6.62M-7.59M-2.41M-10.09M-11.56M
Income towards Parent Company (Quarter)
-0.40M-22.76M-1.33M-1.56M-1.54M-2.05M-2.50M-3.60M-4.34M-0.82M-5.33M-4.41M-7.15M15.30M-4.54M-6.62M-7.59M-2.41M-10.09M-11.56M
Net Income towards Common Stockholders (Quarter)
-0.40M-22.76M-1.33M-1.56M-1.54M-2.05M-2.50M-3.60M-4.34M-0.82M-5.33M-4.41M-7.15M15.30M-4.54M-6.62M-7.59M-2.41M-10.09M-11.56M
Additional items
EPS (Basic) (Quarter)
-0.12-6.20-0.10-0.11-0.11-0.15-0.18-0.24-0.23-0.05-0.23-0.15-0.240.54-0.15-0.22-0.24-0.07-0.18-0.18
EPS (Diluted) (Quarter)
-0.11-0.11-0.15-0.18-0.24-0.23-0.05-0.23-0.15-0.240.54-0.15-0.22-0.24-0.07-0.18-0.18
Shares Outstanding (Quarter)
3.38M3.67M13.83M13.88M13.92M13.89M13.90M15.04M18.58M17.34M23.44M28.79M29.42M28.29M29.70M29.98M31.93M32.97M55.37M63.77M
Shares Outstanding (Diluted) (Quarter)
13.88M13.92M13.89M13.90M15.04M18.58M17.34M23.44M28.79M29.42M28.29M29.70M29.98M31.93M32.97M55.37M63.77M
EBITDA (Quarter)
-0.35M-0.60M-1.33M-1.56M-1.53M-3.79M-2.52M-3.72M-4.52M-5.38M-5.59M-4.70M-7.39M-4.99M-4.68M-6.72M-7.66M-10.89M-10.80M-12.46M
Interest Expenses (Quarter)
0.05M885.00388.00189.00-0.01M7.63M0.52M1.60M1.57M15.76M0.44M0.42M1.51M0.38M0.36M1.34M
Tax Rate (Quarter)
-0.33-0.01-0.12-0.11-0.1145.89-0.21-0.18-0.1684.07-0.17-0.23-0.160.07-0.22-0.13-0.1077.40-0.12